Creatinine

Creatinine

SCHEMBL4332495

CN1CC(=O)NC1=N.N

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Creatinine SCHEMBL288087 0.98 CRBN (0.61)
Creatinine SCHEMBL8809815 0.98 CRBN (0.61)
Creatinine SCHEMBL7203535 0.98
Creatinine SCHEMBL16295 0.98
Creatinine SCHEMBL6473476 0.95
Creatinine SCHEMBL3514057 0.95
Creatinine SCHEMBL435006 0.95
Creatinine SCHEMBL2922002 0.95
Creatinine SCHEMBL21404081 0.95
Creatinine SCHEMBL8637084 0.95

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090311795-A1 BILATERAL CONTROL OF FUNCTIONS TRADITIONALLY REGULATED BY ONLY SEROTONIN OR ONLY DOPAMINE Vidas, Arrett & Steinkraus, P.A. 2009-12-17 US disclosed
WO-2009152426-A1 BILATERAL CONTROL OF FUNCTIONS TRADITIONALLY REGULATED BY ONLY SEROTONIN OR ONLY DOPAMINE HINZ MARTIN (US) 2009-12-17 WO disclosed
US-5763485-A ADMINISTERING TO THE ANIMAL A THERAPEUTICAL AMOUNT OF GLUTAMINE TO REDUCE THE PERMEABILITY OF PATHOGENIC MICROORGANISM SELECTED FROM CANDIDA ALBICANS, STAPHYLOCOCCUS SPECIES, ASPERGILLUS SPECIES AND ESCHERICHIA COLI BRIGHAM AND WOMEN'S HOSPITAL (US) 1998-06-09 US disclosed
US-5684045-A CATABOLIC GUT FOR ANIMALS BRIGHAM AND WOMEN'S HOSPITAL (US) 1997-11-04 US disclosed
US-5607975-A PROMOTING RECOVERY FROM BONE MARROW TRANSPLANTS INTESTINES BRIGHAM AND WOMEN'S HOSPITAL (US) 1997-03-04 US disclosed
US-RE35233-E ADMINISTERING GLUTAMINE BRIGHAM AND WOMEN'S HOSPITAL (US) 1996-05-07 US disclosed
US-5397803-A Use of glutamine to reduce rate of pathogenic microorganism infection BRIGHAM AND WOMEN'S HOSPITAL (US) 1995-03-14 US disclosed
US-5039704-A Administering glutamine BRIGHAM AND WOMEN'S HOSPITAL (US) 1991-08-13 US disclosed
US-4857555-A ADMINISTERING GLUTAMINE BRIGHAM & WOMEN'S HOSPITAL (US) 1989-08-15 US disclosed